Synopsis
Synopsis
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. D-glc
2. D-glucopyranose
3. D-glucopyranoside
4. Glc
5. Glucopyranose
6. Glucopyranoside
7. Glucose
8. 2280-44-6
9. Grape Sugar
10. D-glcp
11. (3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
12. Traubenzucker
13. Glucose Solution
14. Dextrose Solution
15. Chebi:4167
16. Corn Sugar
17. Glucopyranose, D-
18. 54-17-1
19. (3r,4s,5s,6r)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4,5-tetraol
20. Dsstox_cid_2910
21. Rel-(3r,4s,5s,6r)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4,5-tetraol
22. Glucodin
23. Goldsugar
24. Meritose
25. Vadex
26. Clintose L
27. Cpc Hydrate
28. Roferose St
29. A-d-glucose
30. Clearsweet 95
31. A-d-glucopyranose
32. Staleydex 95m
33. Staleydex 111
34. (+)-glucose
35. Cerelose 2001
36. Tabfine 097(hs)
37. 2h-pyran-2,3,4,5-tetraol
38. D-glucopyranose, Anhydrous
39. Glc-ring
40. Cartose Cerelose
41. D-glucose-ring
42. Glucose Injection
43. Glucose 40
44. Staleydex 130
45. Einecs 218-914-5
46. Glc-oh
47. Meritose 200
48. Nchembio867-comp4
49. Dextrose, Unspecified
50. Glucose (jp17)
51. Starbld0000491
52. 6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetraol
53. Anhydrous Glucose ,(s)
54. Glucose, Unspecified Form
55. Dextrose, Unspecified Form
56. Purified Glucose (jp17)
57. Epitope Id:142342
58. D-(+)-dextrose
59. Dsstox_rid_76784
60. Dsstox_rid_82925
61. Dsstox_gsid_22910
62. Dsstox_gsid_48729
63. Gtpl4536
64. Chembl1222250
65. Bdbm34103
66. Dtxsid501015215
67. Dtxsid901015217
68. Tox21_113165
69. Tox21_200145
70. Akos025147374
71. Nsc 287045
72. Cas-50-99-7
73. Ncgc00166293-01
74. Ncgc00257699-01
75. Bs-48662
76. Cas-58367-01-4
77. G0048
78. (3r,4s,5s,6r)-6-(hydroxymethyl)tetrahydro-
79. C00031
80. D00009
81. F71542
82. Q37525
83. Q23905964
84. N_full/o_full_10000000000000_gs_656
85. D-glucose (closed Ring Structure, Complete Stereochemistry)
86. Wurcs=2.0/1,1,0/[a2122h-1x_1-5]/1/
Molecular Weight | 180.16 g/mol |
---|---|
Molecular Formula | C6H12O6 |
XLogP3 | -2.6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 180.06338810 g/mol |
Monoisotopic Mass | 180.06338810 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 151 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
Blood glucose is an obligatory energy source in humans involved in various cellular activities, and it also acts as a signalling molecule for diverse glucose-sensing molecules and proteins. Glucose undergoes oxidation into carbon dioxide, water and yields energy molecules in the process of glycolysis and subsequent citric cycle and oxidative phosphorylation. Glucose is readily converted into fat in the body which can be used as a source of energy as required. Under a similar conversion into storage of energy, glucose is stored in the liver and muscles as glycogen. Glucose stores are mobilized in a regulated manner, depending on the tissues' metabolic demands. Oral glucose tablets or injections serve to increase the supply of glucose and oral glucose administration is more effective in stimulating insulin secretion because it stimulates the incretin hormones from the gut, which promotes insulin secretion.
B - Blood and blood forming organs
B05 - Blood substitutes and perfusion solutions
B05C - Irrigating solutions
B05CX - Other irrigating solutions
B05CX01 - Glucose
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CA - Tests for diabetes
V04CA02 - Glucose
V - Various
V06 - General nutrients
V06D - Other nutrients
V06DC - Carbohydrates
V06DC01 - Glucose
Absorption
Polysaccharides can be broken down into smaller units by pancreatic and intestinal glycosidases or intestinal flora. Sodium-dependent glucose transporter SGLT1 and GLUT2 (SLC2A2) play predominant roles in intestinal transport of glucose into the circulation. SGLT1 is located in the apical membrane of the intestinal wall while GLUT2 is located in the basolateral membrane, but it was proposed that GLUT2 can be recruited into the apical membrane after a high luminal glucose bolus allowing bulk absorption of glucose by facilitated diffusion. Oral preparation of glucose reaches the peak concentration within 40 minutes and the intravenous infusions display 100% bioavailability.
Route of Elimination
Glucose can be renally excreted.
Volume of Distribution
The mean volume of distribution after intravenous infusion is 10.6L.
Clearance
The mean metabolic clearance rate of glucose (MCR) for the 10 subjects studied at the higher insulin level was 2.27 0.37 ml/kg/min at euglycemia and fell to 1.510.21 ml/kg/ at hyperglycemia. The mean MCR for the six subjects studied at the lower insulin level was 1.91 0.31 ml/kg/min at euglyglycemia.
Glucose can undergo aerobic oxidation in conjunction to the synthesis of energy molecules. Glycolysis is the initial stage of glucose metabolism where one glucose molecule is degraded into 2 molecules of pyruvate via substrate-level phosphorylation. These products are transported to the mitochondria where they are further oxidized into oxygen and carbon dioxide.
The approximate half-life is 14.3 minutes following intravenous infusion. Gut glucose half-life was markedly higher in females (79 2 min) than in males (65 3 min, P < 0.0001) and negatively related to body height (r = -0.481; P < 0.0001).
Glucose supplies most of the energy to all tissues by generating energy molecules ATP and NADH during a series of metabolism reactions called glycolysis. Glycolysis can be divided into 2 main phases where the preparatory phase is initiated by the phosphorylation of glucose by a hexokinase to form glucose 6-phosphate. The addition of the high-energy phosphate group activates glucose for subsequent breakdown in later steps of glycolysis and is the rate-limiting step. Products end up as substrates for following reactions, to ultimately convert C6 glucose molecule into two C3 sugar molecules. These products enter the energy-releasing phase where total of 4ATP and 2NADH molecules are generated per one glucose molecule. The total aerobic metabolism of glucose can produce up to 36 ATP molecules. This energy-producing reactions of glucose is limited to D-glucose as L-glucose cannot be phosphorlyated by hexokinase. Glucose can act as precursors to generate other biomolecules such as vitamin C. It plays a role as a signaling molecule to control glucose and energy homeostasis. Glucose can regulate gene transcription, enzyme activity, hormone secretion, and the activity of glucoregulatory neurons. The types, number and kinetics of glucose transporters expressed depends on the tissues and fine-tunes glucose uptake, metabolism, and signal generation in order to preserve cellular and whole body metabolic integrity.
Certificate Number : R1-CEP 1997-059 - Rev 04
Status : Valid
Issue Date : 2022-04-05
Type : Chemical
Substance Number : 178
Certificate Number : R1-CEP 2004-274 - Rev 03
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2016-05-09
Type : Chemical
Substance Number : 177
Certificate Number : R1-CEP 2015-315 - Rev 00
Status : Valid
Issue Date : 2022-03-03
Type : Chemical
Substance Number : 178
Certificate Number : CEP 2021-188 - Rev 01
Status : Valid
Issue Date : 2024-01-31
Type : Chemical
Substance Number : 178
Certificate Number : CEP 2021-200 - Rev 01
Status : Valid
Issue Date : 2024-01-31
Type : Chemical
Substance Number : 177
Certificate Number : CEP 2017-079 - Rev 01
Status : Valid
Issue Date : 2024-01-31
Type : Chemical
Substance Number : 177
Certificate Number : R0-CEP 2020-019 - Rev 00
Status : Valid
Issue Date : 2022-01-14
Type : Chemical
Substance Number : 178
About the Company : CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093. HK) is a leading pharmaceutical group in China. It was established in 1997. Since the very beginning, CSPC has taken ...
About the Company : Welcome To The Most Famous And Reputed Manufacturer And Supplier For Pharmaceutical Products, Chemicals, Pharmaceutical Package Group In China. FENGCHEN GROUP CO., LTD Have Been Se...
About the Company : Hefei TNJ Chemical Industry, established in 2001, is a key chemical manufacturer and supplier in China. In 2001, three young chemists from a local large state-owned chemical facto...
About the Company : We are working in this business since last 14 years, supplying chemicals of all Grades & Quality to our valued customers in major Industries, entirely to their satisfaction and at ...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
About the Company : Tereos Syral is a leading European producer of starch-based pharmaceutical excipients and actives, used in solid and liquid dosage forms, medicated confectionery and clinical nutri...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Glucose; Sodium Chloride; Potassium Chloride; Sodium Citrate Dihydrate
Brand Name : Elotrans
Dosage Form : Powder For Oral Solution
Dosage Strength :
Packaging :
Approval Date : 17/03/1983
Application Number : 44644
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Deregistered
Registration Country : Sweden
Glucose (Anhydrous); Potassium Chloride; Sodium Citrate (Dihydrate); Sodium Chloride
Brand Name : Aqurex
Dosage Form : Powder For Oral Solution
Dosage Strength :
Packaging :
Approval Date : 28/06/2012
Application Number : 20110302000234
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Glucose B Braun
Dosage Form : Infusion Solution
Dosage Strength : 100g/1000ml
Packaging :
Approval Date : 08/03/1963
Application Number : 29550
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : GLUCOSE BAXTER
Dosage Form : Bottle
Dosage Strength : 0.05
Packaging : 500 ML 5% - PARENTERAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Glucio
Dosage Form : Glucose 5% 500Ml Parenteral Use
Dosage Strength : 1 Bottle 500 ml 5%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : DIACO GLUCOSE
Dosage Form : Bottle
Dosage Strength : 0.05
Packaging : 250 ML 5% - PARENTERAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Authorized
Registration Country : Spain
Anhydrous Glucose; Sodium Chloride; Sodium Lactate; Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate
Brand Name : Capd/Dpca
Dosage Form : Solution For Peritoneal Dialysis
Dosage Strength :
Packaging :
Approval Date : 1998-04-01
Application Number : 61886
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Deregistered
Registration Country : Sweden
Glucose (Anhydrous); Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate; Sodium Chloride; Sodium Lactate
Brand Name : Capd/Dpca 10
Dosage Form : Dialysis Solution
Dosage Strength :
Packaging :
Approval Date : 08/10/1993
Application Number : 19931008000014
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Glucose (Anhydrous); Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate; Sodium Chloride; Sodium Lactate
Brand Name : Capd/Dpca 3
Dosage Form : Dialysis Solution
Dosage Strength :
Packaging :
Approval Date : 09/12/1983
Application Number : 19831209000021
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Glucose Sodium Chloride Ii
Dosage Form :
Dosage Strength : 1 Bottle 1,000 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
70
PharmaCompass offers a list of Glucose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glucose manufacturer or Glucose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glucose manufacturer or Glucose supplier.
PharmaCompass also assists you with knowing the Glucose API Price utilized in the formulation of products. Glucose API Price is not always fixed or binding as the Glucose Price is obtained through a variety of data sources. The Glucose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_2910 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_2910, including repackagers and relabelers. The FDA regulates DSSTox_CID_2910 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_2910 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_2910 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_2910 supplier is an individual or a company that provides DSSTox_CID_2910 active pharmaceutical ingredient (API) or DSSTox_CID_2910 finished formulations upon request. The DSSTox_CID_2910 suppliers may include DSSTox_CID_2910 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_2910 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_2910 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_2910 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_2910 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_2910 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_2910 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_2910 USDMF includes data on DSSTox_CID_2910's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_2910 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_2910 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_CID_2910 Drug Master File in Japan (DSSTox_CID_2910 JDMF) empowers DSSTox_CID_2910 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_CID_2910 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_2910 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_CID_2910 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_CID_2910 Drug Master File in Korea (DSSTox_CID_2910 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_2910. The MFDS reviews the DSSTox_CID_2910 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_2910 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_CID_2910 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_2910 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_CID_2910 suppliers with KDMF on PharmaCompass.
A DSSTox_CID_2910 CEP of the European Pharmacopoeia monograph is often referred to as a DSSTox_CID_2910 Certificate of Suitability (COS). The purpose of a DSSTox_CID_2910 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DSSTox_CID_2910 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DSSTox_CID_2910 to their clients by showing that a DSSTox_CID_2910 CEP has been issued for it. The manufacturer submits a DSSTox_CID_2910 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DSSTox_CID_2910 CEP holder for the record. Additionally, the data presented in the DSSTox_CID_2910 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DSSTox_CID_2910 DMF.
A DSSTox_CID_2910 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DSSTox_CID_2910 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DSSTox_CID_2910 suppliers with CEP (COS) on PharmaCompass.
DSSTox_CID_2910 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_2910 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_2910 GMP manufacturer or DSSTox_CID_2910 GMP API supplier for your needs.
A DSSTox_CID_2910 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_2910's compliance with DSSTox_CID_2910 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_2910 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_2910 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_2910 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_2910 EP), DSSTox_CID_2910 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_2910 USP).